Lucintel anticipates that North America will be the fastest growing region in the epigenetic market


   October 24, 2019
According to a new market report by Lucintel, the future of the epigenetic market looks promising with opportunities in pharmaceutical and biotechnology industries. The epigenetic market is expected to grow with a CAGR of 13% from 2019 to 2024. The major growth drivers for this market are surge in prevalence of cancer, rising geriatric population, technological advancements in epigenetics research, and availability of government funding.

To download report brochure, please go to https://www.lucintel.com/epigenetic-market.aspx and click "report brochure" tab

In this market, enzymes, instruments and consumables, kits, reagents, and bioinformatics tools are used to make changes to the function and/or regulation of molecules, without altering their primary sequences. Kits is the largest segment.

Within the epigenetic market, oncology is the largest application due to increasing prevalence of cancer worldwide.

North America is the largest market over the forecast period due to research activities on epigenetics by government funding, presence of advanced healthcare facilities, and continual advancements in diagnostic procedures.

Illumina, Thermo Fisher Scientific, Merck Millipore, Abcam, Active Motif, Bio-Rad, New England Biolabs, Agilent, and Qiagen are among the major manufacturers of the epigenetic market.

Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the epigenetic market by product, application, end use industry, technology, and region. Lucintel has prepared a comprehensive research report titled "Epigenetic Market 2019-2024: Trends, Forecast, and Opportunity Analysis". This Lucintel report serves as a catalyst for growth strategy as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the epigenetic market by product, application, end use industry, technology, and region as follows:

By Product [$M shipment analysis for 2013 – 2024]:



  • Enzymes


  • Instruments and Consumables


  • Kits


  • Reagents


  • Bioinformatics Tools


By Application [$M shipment analysis for 2013 – 2024]:



  • Oncology


  • Non Oncology


By End Use Industry [$M shipment analysis for 2013 – 2024]:



  • Pharmaceutical


  • Biotechnology


  • Others


By Technology [$M shipment analysis for 2013 – 2024]:



  • DNA Methylation


  • Histone Methylation


  • Histone Acetylation


  • Large noncoding RNA


  • MicroRNA Modification


  • Chromatin structures


  • Others


By Region [$M shipment analysis for 2013 – 2024]:



  • North America


    • United States


    • Canada


    • Mexico




  • Europe


    • UK


    • Germany


    • Italy




  • Asia Pacific


    • China


    • Japan


    • India




  • Rest of the World


This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/epigenetic-market.aspx or helpdesk@lucintel.com.

About Lucintel

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.


Lucintel Corporate Customers

Market Entry, M & A, Opportunity Screening,...

Private Equity Customers

Buy Side Services (target screening, due diligence, ..)

Market Research Reports

Aerospace & Defense [51]
Chemical [258]
Composites & Advanced Materials [159]
Construction & Industrial [68]
Consumer and Retail [120]
Economic Analysis [86]
Energy & Utility [73]
Finance & Services [10]
Healthcare [62]
Media & Entertainment [16]
Metals & Mining [17]
Technology & Telecommunication [162]
Transportation [140]

Customer Quotes

"With more than 20 years experience in the industry, this is the first time we have come across such an extensive market analysis for our industry." Ven Cote, CEO, ZCL

"The insights we gained from Lucintel work helped with our business plan…a wonderful professional job…" Mike Jackson, Stahlin

"The report from Lucintel is useful not only for business planners, but also for the technology officers wanting to create a roadmap …" Dr. Giulio Ranzo, Booz Allen

"The information is so comprehensive, it has allowed us to identify & focus our business development efforts. It saved months of leg-work." Bill Barz, L&L Products

"We bought Lucintel report because it is the best report about our industry…a complete and appropriate analysis." Cesare Andrenacci, Ferretti

Quick Query

Lucintel Insights in News

Follow us on